Literature DB >> 2786848

The Zucker fatty rat as a genetic model of obesity and hypertension.

T W Kurtz1, R C Morris, H A Pershadsingh.   

Abstract

The association of hypertension with obesity has long been recognized; however, because of the lack of suitable animal models of obesity and hypertension, the pathogenesis of the high blood pressure associated with obesity remains poorly understood. We hypothesized that the Zucker fatty rat, a widely studied model of obesity and insulin resistance, might also be characterized by hypertension. Mean arterial pressure directly measured in the unanesthetized, unrestrained obese (fatty) Zucker rat was significantly greater than in two strains of nonobese control rats, the lean Zucker rat and the Lewis rat. The greater blood pressure in the obese rats was not dependent on hyperphagia or increased body weight per se since moderate caloric restriction, achieved by pair-feeding with lean rats, decreased weight gain but did not attenuate hypertension. Pair-fed obese rats retained less sodium than lean control rats, suggesting that greater blood pressure in the obese rats is not a consequence of increased renal retention of sodium. A unique feature of the Zucker strain is that the increased blood pressure appears to be specifically associated with the obese genotype. The findings suggest that the obese Zucker rat might provide a useful experimental model of obesity and hypertension.

Entities:  

Mesh:

Year:  1989        PMID: 2786848     DOI: 10.1161/01.hyp.13.6.896

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  51 in total

1.  Comparison of adipocyte-specific gene expression from WNIN/Ob mutant obese rats, lean control, and parental control.

Authors:  S L Madhira; G Nappanveethl; V Kodavalla; V Venkatesan
Journal:  Mol Cell Biochem       Date:  2011-06-02       Impact factor: 3.396

2.  High Na intake increases renal angiotensin II levels and reduces expression of the ACE2-AT(2)R-MasR axis in obese Zucker rats.

Authors:  Preethi Samuel; Quaisar Ali; Rifat Sabuhi; Yonnie Wu; Tahir Hussain
Journal:  Am J Physiol Renal Physiol       Date:  2012-05-16

3.  Nebivolol improves diastolic dysfunction and myocardial remodeling through reductions in oxidative stress in the Zucker obese rat.

Authors:  Xinli Zhou; Lixin Ma; Javad Habibi; Adam Whaley-Connell; Melvin R Hayden; Roger D Tilmon; Ashley N Brown; Jeong-A Kim; Vincent G Demarco; James R Sowers
Journal:  Hypertension       Date:  2010-02-22       Impact factor: 10.190

4.  Experimental models of non-alcoholic fatty liver disease in rats.

Authors:  Otto Kucera; Zuzana Cervinkova
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

Review 5.  Proteomics and diabetic nephropathy: what have we learned from a decade of clinical proteomics studies?

Authors:  Massimo Papale; Salvatore Di Paolo; Grazia Vocino; Maria Teresa Rocchetti; Loreto Gesualdo
Journal:  J Nephrol       Date:  2014-02-25       Impact factor: 3.902

6.  Expression of gLTP in sympathetic ganglia of obese Zucker rats in vivo: molecular evidence.

Authors:  K H Alzoubi; A M Aleisa; K A Alkadhi
Journal:  J Mol Neurosci       Date:  2008-06-19       Impact factor: 3.444

7.  Leptin receptor deficiency is associated with upregulation of cannabinoid 1 receptors in limbic brain regions.

Authors:  Panayotis K Thanos; Roberto C Ramalhete; Michael Michaelides; Yianni K Piyis; Gene-Jack Wang; Nora D Volkow
Journal:  Synapse       Date:  2008-09       Impact factor: 2.562

8.  In situ glucose uptake and glucokinase activity of pancreatic islets in diabetic and obese rodents.

Authors:  Y Liang; S Bonner-Weir; Y J Wu; C D Berdanier; D K Berner; S Efrat; F M Matschinsky
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

Review 9.  Diabetes and cardiovascular autonomic dysfunction: application of animal models.

Authors:  Katia De Angelis; Maria Claudia Irigoyen; Mariana Morris
Journal:  Auton Neurosci       Date:  2008-12-02       Impact factor: 3.145

10.  The prostacyclin analog beraprost sodium ameliorates characteristics of metabolic syndrome in obese Zucker (fatty) rats.

Authors:  Nahoko Sato; Masayuki Kaneko; Mitsutaka Tamura; Hajimu Kurumatani
Journal:  Diabetes       Date:  2010-01-12       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.